Shares of Catheter Precision, Inc. (NYSEAMERICAN:VTAK – Get Free Report) shot up 2.5% during mid-day trading on Tuesday . The company traded as high as $0.44 and last traded at $0.44. 94,084 shares traded hands during mid-day trading, a decline of 91% from the average session volume of 1,044,929 shares. The stock had previously closed at $0.43.
Catheter Precision Price Performance
The company has a debt-to-equity ratio of 0.12, a quick ratio of 0.65 and a current ratio of 0.66.
Catheter Precision Company Profile
Catheter Precision, Inc designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company’s lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures.
Featured Articles
- Five stocks we like better than Catheter Precision
- 3 Warren Buffett Stocks to Buy Now
- Super Micro Computer Soars 28%: Is It Really Out of the Woods?
- How to Use Stock Screeners to Find Stocks
- Traders Are Flocking Back to Oil: What’s Fueling the Optimism
- Breakout Stocks: What They Are and How to Identify Them
- 3 Hot Stock Trends to Ride Into 2025
Receive News & Ratings for Catheter Precision Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catheter Precision and related companies with MarketBeat.com's FREE daily email newsletter.
